ARCHIVES

Ibrutinib Increases OS, PFS Versus Ofatumumab in Phase III

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Cancer Control Survey “a Flop,” Advisory committee Members Say

October 11, 1974

DCCR Receives 59 Community Hospital Oncology Program Proposals, Only here From Rural Areas

September 21, 1979

ACS Probably Will Accept Hammer’s Offer On Matching Funds For Survey

February 3, 1984

New Treatment Approaches For A Variety Of Leukemias Described At ASH Meeting

January 30, 2004

Connie Mack Joins Washington Office Of Shaw Pittman.

March 2, 2001

$1.5 Million In Direct Costs Is Proposed Core Grant Requirement

July 12, 1991